ICOS and breast cancer: Additional flow cytometry immunophenotyping showed that HLA-DR+ Tregs infiltrating BC preferentially coexpress CCR8, ICOS and IRF4 (Fig. 4e), thereby revealing immunophenotypic overlap with activated Tregs described in other tumors.